Prosecution Insights
Last updated: April 19, 2026

Spinalcyte LLC

5 pending office actions

Portfolio Summary

5
Total Pending OAs
1
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17755837 FIBROBLAST-BASED THERAPY FOR TREATMENT AND PREVENTION OF STROKE FOX, ALLISON M 1633 Non-Final OA May 10, 2022
17453143 FIBROBLASTS FOR TREATMENT OF DEGENERATIVE DISC DISEASE PYLA, EVELYN Y 1633 Final Rejection Nov 01, 2021
17303133 METHODS OF ENHANCING FIBROBLAST THERAPEUTIC ACTIVITY BARRON, SEAN C 1653 Non-Final OA May 20, 2021
17052841 DE-DIFFERENTIATED FIBROBLAST-CONDITIONED MEDIA FOR STIMULATION OF DISC REGENERATION MIANO, JOSEPH PAUL 1631 Non-Final OA Nov 04, 2020
16068096 CELLULAR BLEND FOR THE REGENERATION OF CHONDROCYTES OR CARTILAGE TYPE CELLS CORDAS, EMILY ANN 1632 Non-Final OA Dec 17, 2018

Managing Spinalcyte LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month